# Self-Financed Growth and the Balance Sheet ## The leverage ceiling is the strategy, not a policy The best acquisition-driven compounders — Addtech, Lifco, Lagercrantz, Indutrade — operate at roughly **1–2× net debt / EBITDA and never above 2.5×** (REQ, Jul 2025, p.111, p.153). REQ's portfolio evidence: the Nordic fund runs **1.3× on a portfolio-weighted basis vs 1.9× for the peer group**, and 1.7× equally weighted (p.157). > [!important] Low leverage is not caution, it is optionality > A strong balance sheet is what lets a company keep acquiring **when conditions are bad and prices are best**. Too much debt removes the ability to act opportunistically, and can force divestments at distressed valuations (p.196). ## The Great Financial Crisis, as a natural experiment Across REQ's selection of Nordic acquirers in 2008–2010: **55% of operating cash flow went to M&A, 37% to dividends** (p.146). Year by year, M&A was 64% of operating cash flow in 2008, 22% in 2009 and 59% in 2010 — they paused, they didn't stop. The mechanism that made that possible is counter-intuitive and worth internalising: > [!tip] Working capital is the shock absorber > When sales fall, these businesses **release** net working capital. In 2009 every company in the sample had a positive NWC movement, and on average the release compensated for **78% of the fall in funds from operations** (p.150). Organic growth stalls, cash flow holds up, and the acquisition engine keeps running. That is the dual engine working in the direction nobody models. ## The drawdowns tell the whole story Share price performance through the GFC, sorted by where the balance sheet started (p.158): | Company | Peak ND/EBITDA (2007–10) | Max drawdown | | --- | --- | --- | | Addnode | net cash (−1.6×) | **−8.9%** | | OEM | net cash (−0.5×) | −19.0% | | Beijer Alma | ~0.1× | −25.9% | | Indutrade | 1.5× | −46.0% | | Bergman & Beving | **4.2×** | **−76.2%** | | Xano | **7.8×** | **−75.2%** | And the highly levered names did not recover as strongly afterwards either. The same relationship reappeared in 2022: share price decline regressed against net debt/EBITDA gave R² of 0.34–0.41 (p.170). ## Equity issuance The traditional compounders — Addtech, Addnode, Indutrade, Lagercrantz, Lifco — **do not use equity as a growth tool**, because it dilutes. Newly listed companies and those pivoting to a more aggressive M&A agenda do, and issuance rose sharply in 2020–21 in both absolute and relative terms (p.196). The honest case for issuing: fast, raises a lot at a high valuation with little dilution, aligns the seller, brings in respectable long-term holders. The case against: destroys value when the stock is undervalued; in bad sentiment sellers demand cash anyway; lock-up expiry creates a selling flood; and **previous sellers left out-of-the-money on shares get demotivated, which shows up in operating performance** (p.197). A Credit Suisse study (Mauboussin, Callahan, Majd) found the market responds more favourably to cash deals — the buyer taking all the risk signals confidence, while stock is a hedge against not capturing the synergies the premium demands. ## Why it matters Leverage is the single variable that converts a good acquisition-driven compounder into a broken one. It is also the easiest thing on this list to check in five minutes. ## Related - [[Acquisition-Driven Compounders MOC]] - [[Case Files - When Compounders Break]] - [[Acquisition Multiples and Deal Structure]] - [[Profit over Working Capital]] - [[Investing Discipline]]